about
Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients.An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer.Nutrigenetics, nutrigenomics, and selenium.A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet.Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New ZealandSelenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand.An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer.Benefits of Selenium Supplementation on Leukocyte DNA Integrity Interact with Dietary Micronutrients: A Short Communication.Beyond PSA: are new prostate cancer biomarkers of potential value to New Zealand doctors?Influence of Aldo-keto reductase 1C3 in prostate cancer -a mini review.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.SNP-SNP interactions as risk factors for aggressive prostate cancer.Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APCMIN Mouse Model.Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study.Epigenetic events and protection from colon cancer in New Zealand.Prostate disease risk factors among a New Zealand cohort.Aggressive prostate cancer incidence in New Zealand-"united we fall, divided we stand".Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand.Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.Correction: Vaidyanathan et al. Are We Eating Our Way to Prostate Cancer-A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150. Non-Coding RNA 2016, 2, 2.Are We Eating Our Way to Prostate Cancer-A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150.Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer riskOxidative DNA damage and repair: significance and biomarkersSelenium Supplementation and Prostate Health in a New Zealand Cohort
P50
Q28385758-BD03FF53-48E2-4EE0-B7FE-77918199E039Q34241765-18234D72-3328-48F6-9530-BC04BC895969Q35003821-1BDA86E6-DA35-4A2D-BC2F-BF855ADAF61FQ35711019-6E63ABA1-48B6-40B6-BA6E-1AD3146F0744Q35824866-A1394F39-06DC-4455-A439-A61A9A7651D6Q35829609-920FEEB0-6710-4F82-B79B-57E8642F17B5Q35863338-F77BDE66-1B45-4B6A-BE6C-172B2D479630Q36329698-E11F5C34-ECB8-4F15-976C-5D43C6119985Q36663319-BA449ADB-41DF-466E-8BA1-9D31E10349A9Q36941702-8AEF1122-6ABD-47E3-AB52-0D1437E2A3BDQ38004357-B2A039B6-C9C9-482B-AE83-857835DD82C2Q38737622-56102AAF-8FEB-43A7-9017-3C39648FE8B7Q40311743-A2B9B8DA-3F4B-4445-916D-CD89826FA772Q42054665-13BFE563-1EA7-450D-88B3-2DDDF098274AQ42287119-988A92E3-B33C-4E04-936B-AC543FCAF669Q42375631-BF288CF4-6A44-4F32-990D-3E452AD48043Q44938471-31396EF5-83D2-47D3-BD12-DCCAA4982ED5Q45330916-88E5D387-58F7-4406-B5F1-F46B31921EAAQ47290326-47F88456-8EE8-4E4D-93DC-7124152357CFQ50493191-CDD8557A-0F3C-433D-8D4E-65105A4F9A80Q51804729-57EC6927-1D2C-4D4C-9B38-85585EEF0CF4Q54695964-C00224EF-32C8-49E5-9189-86C4A715886DQ55085682-9956B783-FC88-4ED7-A5A5-86E9AB90FB30Q55279832-A84E8D2E-6C9E-4764-9B81-8348EF09498CQ55344474-75F7A2D5-7CF9-4558-8ECC-766CE54C7787Q64890581-9D6157DB-AF02-4F92-A180-6B281C7585C8Q79954773-B8D6C3CF-2B99-44EB-A7BE-A6DBBEB3836FQ80305453-2789BBA5-6291-4E8F-9476-8B1A8F883A7CQ92153009-FEB1730C-0A13-464F-9476-D582351D277C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6383-4163
@en
name
Nishi Karunasinghe
@ast
Nishi Karunasinghe
@en
Nishi Karunasinghe
@es
Nishi Karunasinghe
@nl
type
label
Nishi Karunasinghe
@ast
Nishi Karunasinghe
@en
Nishi Karunasinghe
@es
Nishi Karunasinghe
@nl
prefLabel
Nishi Karunasinghe
@ast
Nishi Karunasinghe
@en
Nishi Karunasinghe
@es
Nishi Karunasinghe
@nl
P106
P31
P496
0000-0002-6383-4163